genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • wound care
      Circadian Rhythm

      Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing

      AI
      Antibodies

      AI-Based Strategy Boosts High-Affinity Antibody Drug Discovery

      Artificial intelligence
      Artificial Intelligence

      BenchSci Launches AI Tool to Map Disease Biology for Preclinical Drug…

      Diabetes

      Type 1 Diabetes May Be Treatable with Immunological Drug

      cancer vaccine
      Cancer

      Remodeling How Cancer Vaccines Are Designed

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      AAV (Adeno-associated virus)

      AAV Manufacturing Sees Big Opportunities in Synthetic Biology

      Antibodies

      On Demand Could Meet Requirements for Low-Volume Production

      Bioprocessing

      Corralling Complexity in the Cloud

      Bioprocessing

      U.K. to Introduce Regulations for Biomanufacturing at Point-of-Care

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Virology HCV

HCV

  • Coronavirus
  • Dengue
  • Ebola
  • HBV
  • HCV
  • Herpes
  • HIV
  • HPV
  • Influenza
  • West Nile Virus
  • Zika
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    HCV

    Gilead Grows Antiviral Pipeline with Novartis, DURECT Licensing Deals

    Regulus Therapeutics has begun a restructuring that includes elimination of 60% of its workforce and a voluntary pause of its Phase I study for RGLS4326
    HCV

    Regulus Axing 60% of Workforce, Pauses Patient Recruitment for Lead Program

    HCV

    Ascletis Licenses Medivir HCV Drug Candidate for Greater China

    HCV

    Virus Hijacks MicroRNA to Ensure its Propagation

    Recently Featured

    AAV Manufacturing Sees Big Opportunities in Synthetic Biology

    AAV Manufacturing Sees Big Opportunities in Synthetic Biology

    On Demand Could Meet Requirements for Low-Volume Production

    On Demand Could Meet Requirements for Low-Volume Production

    U.K. to Introduce Regulations for Biomanufacturing at Point-of-Care

    U.K. to Introduce Regulations for Biomanufacturing at Point-of-Care

    Bob Langer Answers Your Webinar Questions

    Bob Langer Answers Your Webinar Questions

    Read the Digital Edition

    GEN 2022 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up